Novavax Inc is trading at $9.71 (up 5.5%) on June 17, 2026, extending its recent rally as the stock maintains strong technical momentum following its 2025 profitability turnaround.
- The move appears to be a continuation of recent strength and bullish sentiment, with no new company-specific headlines, FDA decisions, or earnings reports emerging today.
- Investors continue to react positively to the company's improved financial position and long-term outlook established during its 2025 turnaround.